About Michael Kane
Form D filings for Candesant Biomedical in 2023 list Michael Kane as director.
Michael Kane first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Kane in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Kane works with at each company, as listed on that company's latest Form D.
Candesant Biomedical, Inc. · Form D, Jun 6, 2023
KL
Karen Long
Director
BH
Brad Hauser
Director
NH
Niquette Hunt
President and Chief Executive Officer, director
MK
Mary Beth Kreissler
Executive officer
SB
Samara Braunstein
Director
EM
Eileen McGuire
Director